Rice Hall James & Associates’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,603,458
Closed -$24.3M 275
2022
Q3
$24.3M Sell
1,603,458
-241,169
-13% -$3.65M 1.41% 15
2022
Q2
$13.8M Buy
1,844,627
+166,018
+10% +$1.25M 0.67% 45
2022
Q1
$15.3M Buy
1,678,609
+475,017
+39% +$4.32M 0.61% 50
2021
Q4
$8.45M Sell
1,203,592
-29,008
-2% -$204K 0.3% 71
2021
Q3
$14.1M Sell
1,232,600
-8,083
-0.7% -$92.1K 0.52% 60
2021
Q2
$19.9M Sell
1,240,683
-157,383
-11% -$2.52M 0.71% 49
2021
Q1
$25M Buy
1,398,066
+29,058
+2% +$519K 0.81% 38
2020
Q4
$18.5M Sell
1,369,008
-43,170
-3% -$583K 0.65% 47
2020
Q3
$16.6M Buy
1,412,178
+155,260
+12% +$1.83M 0.67% 48
2020
Q2
$18.6M Sell
1,256,918
-29,213
-2% -$431K 0.8% 40
2020
Q1
$17.4M Buy
1,286,131
+173,404
+16% +$2.34M 0.97% 30
2019
Q4
$26.9M Buy
1,112,727
+389,102
+54% +$9.4M 0.91% 30
2019
Q3
$13.9M Buy
723,625
+185,376
+34% +$3.56M 0.5% 84
2019
Q2
$15.9M Buy
538,249
+4,992
+0.9% +$148K 0.53% 69
2019
Q1
$25.3M Buy
533,257
+75,752
+17% +$3.6M 0.82% 36
2018
Q4
$16.5M Buy
457,505
+179,432
+65% +$6.48M 0.6% 54
2018
Q3
$17.1M Sell
278,073
-6,689
-2% -$412K 0.61% 62
2018
Q2
$19.2M Buy
284,762
+9,563
+3% +$646K 0.7% 52
2018
Q1
$14.9M Buy
275,199
+6,038
+2% +$328K 0.58% 69
2017
Q4
$16.1M Buy
269,161
+33,927
+14% +$2.03M 0.63% 65
2017
Q3
$11.4M Sell
235,234
-9,561
-4% -$465K 0.51% 80
2017
Q2
$12.9M Buy
244,795
+46,482
+23% +$2.44M 0.56% 77
2017
Q1
$8.99M Sell
198,313
-562
-0.3% -$25.5K 0.44% 87
2016
Q4
$7.53M Buy
198,875
+817
+0.4% +$30.9K 0.38% 89
2016
Q3
$7.48M Buy
198,058
+39,126
+25% +$1.48M 0.39% 87
2016
Q2
$2.8M Buy
158,932
+1,909
+1% +$33.6K 0.16% 114
2016
Q1
$1.91M Buy
157,023
+2,790
+2% +$33.9K 0.11% 179
2015
Q4
$3.76M Buy
154,233
+75,857
+97% +$1.85M 0.21% 103
2015
Q3
$1.39M Buy
+78,376
New +$1.39M 0.09% 216